APG Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,300
Closed -$258K – 777
2023
Q1
$258K Sell
1,300
-300
-19% -$72K ﹤0.01% 726
2022
Q4
$352K Sell
1,600
-2,731
-63% -$501K ﹤0.01% 761
2022
Q3
$596K Hold
4,331
– – ﹤0.01% 706
2022
Q2
$670K Sell
4,331
-1,000
-19% -$156K ﹤0.01% 705
2022
Q1
$904K Sell
5,331
-400
-7% -$85K ﹤0.01% 703
2021
Q4
$1.36M Buy
5,731
+600
+12% +$203K ﹤0.01% 644
2021
Q3
$1.61M Sell
5,131
-1,655
-24% -$541K ﹤0.01% 661
2021
Q2
$1.96M Sell
6,786
-16,364
-71% -$5.42M ﹤0.01% 664
2021
Q1
$6.86M Sell
23,150
-2,250
-9% -$745K 0.01% 524
2020
Q4
$5.36M Sell
25,400
-5,700
-18% -$1.57M 0.01% 631
2020
Q3
$7.6M Sell
31,100
-7,100
-19% -$1.67M 0.01% 610
2020
Q2
$6.41M Buy
38,200
+11,000
+40% +$1.79M 0.01% 644
2020
Q1
$3.35M Buy
+27,200
New +$4.25M 0.01% 719

Other funds holding ONC

APG Asset Management's ONC Position: Q2 2023 in Review

APG Asset Management sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 1,300 shares — an estimated $258K sold.

APG Asset Management first reported a position in ONC in Q1 2020 and held it in 13 quarters. The position peaked at $7.6M in Q3 2020. 208 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

  • APG Asset Management reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
  • APG Asset Management sold 1,300 BeOne Medicines Ltd shares in Q2 2023, an estimated $258K.
  • APG Asset Management first reported a position in BeOne Medicines Ltd in Q1 2020 and held it in 13 quarters.
  • APG Asset Management's BeOne Medicines Ltd position peaked at $7.6M in Q3 2020.
  • 208 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on APG Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.